Caricamento...
High CCR4 expression in the tumor microenvironment is a poor prognostic indicator in lung adenocarcinoma
BACKGROUND: Clinical trials of anti-CCR4 antibody for solid cancers with or without other immune-modulating agents including immune checkpoint blockade therapy are currently underway. However, little is known about the roles of CCR4(+) lymphocytes and their prognostic impact in lung cancer. We hypot...
Salvato in:
| Pubblicato in: | J Thorac Dis |
|---|---|
| Autori principali: | , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6129889/ https://ncbi.nlm.nih.gov/pubmed/30233846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.07.45 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|